跳至主要内容
临床试验/JPRN-UMIN000003496
JPRN-UMIN000003496招募中2 期

Multicenter Phase II study of TS-1 and gemcitabine combination therapy for elderly patients with unresectable pancreatic cancer. - TS-1/gemcitabine regimen in elderly patients with pancreatic cancer.

Ochanomizu Gastrointestinal Oncology Group0 个研究点目标入组 30 人开始时间: 2010年4月15日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Pulmonary fibrosis or interstitial pneumonia 2) Active double cancer, or history of cancer unless it was surgically removed intraepithrial cancer or is considered to be cured with no less that 10 years of recurrence-free 3) Severe complications, such as (1)poorly controlled diabetes melitus and hypertension (2)poorly controlled angina pectoris, heart failure, or myocardial infarction (3)active infection (4)other diseases with inadequate physical condition, such as ileus, bleeding tendency and diarrhea 4) Symptomatic metastasis in central nervous system 5) Severe mental disorders 6) History of drug hypersensitivity

研究者

发起方
Ochanomizu Gastrointestinal Oncology Group

相似试验